骶神经调节的新技术和应用：更新。
New Technologies and Applications in Sacral Neuromodulation: An Update.
机构信息
Department of Urology, University Hospital Antwerpen, Antwerp, Belgium.
Department of Urology, Antwerp Surgical Training, Anatomy and Research Centre (ASTARC), Faculty of Medicine and Health Sciences, Wlrijk, Belgium.
出版信息
Adv Ther. 2020 Feb;37(2):637-643. doi: 10.1007/s12325-019-01205-z. Epub 2019 Dec 24.
Abstract
Recently rechargeable devices have been introduced for sacral neuromodulation (SNM) with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-free SNM device represents the standard implant; however, it is only approved for MRI head scans. As further new technologies with broader MRI capabilities are emerging, the advantages as well as disadvantages of both rechargeable versus recharge-free devices will be briefly discussed in this commentary from the perspective of patients, healthcare professionals, and providers.
摘要
最近推出了可充电设备用于骶神经调节 (SNM)，全身磁共振成像 (MRI) 的安全性有条件保障。目前，无充电功能的 SNM 设备是标准植入物；然而，它仅批准用于头部 MRI 扫描。随着具有更广泛 MRI 功能的新技术不断涌现，本文将从患者、医疗保健专业人员和提供者的角度简要讨论可充电与无充电设备的优缺点。
相似文献
1
New Technologies and Applications in Sacral Neuromodulation: An Update.
Adv Ther. 2020 Feb;37(2):637-643. doi: 10.1007/s12325-019-01205-z. Epub 2019 Dec 24.
2
[Neuromodulation of lower urinary tract dysfunction].
Urologe A. 2017 Dec;56(12):1591-1596. doi: 10.1007/s00120-017-0526-x.
3
Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?
Prog Urol. 2022 Sep;32(10):672-680. doi: 10.1016/j.purol.2022.04.011. Epub 2022 Jun 22.
4
Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
Am J Obstet Gynecol. 2018 Jul;219(1):78.e1-78.e9. doi: 10.1016/j.ajog.2018.04.005. Epub 2018 Apr 7.
5
Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Neurourol Urodyn. 2019 Aug;38(6):1595-1601. doi: 10.1002/nau.24018. Epub 2019 May 1.
6
A method for securing the temporary lead(s) in sacral nerve stimulation.
Ann R Coll Surg Engl. 2018 Mar;100(3):247-248. doi: 10.1308/rcsann.2017.0134. Epub 2017 Jul 6.
7
What Is New in Neuromodulation?
Curr Urol Rep. 2019 Aug 7;20(9):55. doi: 10.1007/s11934-019-0920-6.
8
Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder.
Neurourol Urodyn. 2018 Feb;37(S2):S17-S22. doi: 10.1002/nau.23476. Epub 2018 Jan 16.
9
Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction.
Expert Rev Med Devices. 2017 Jan;14(1):3-14. doi: 10.1080/17434440.2017.1268913. Epub 2016 Dec 11.
10
Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome.
Neurourol Urodyn. 2017 Mar;36(3):727-733. doi: 10.1002/nau.23008. Epub 2016 Apr 6.
引用本文的文献
1
Electroconvulsive therapy in a patient with an implanted sacral neurostimulator: a case report on safe administration and short-term outcomes.
Front Psychiatry. 2025 Aug 15;16:1563519. doi: 10.3389/fpsyt.2025.1563519. eCollection 2025.
2
Updates in pelvic neuromodulation: the role of pelvic neuromodulation in pelvic disorders.
Front Urol. 2024 Mar 15;4:1329305. doi: 10.3389/fruro.2024.1329305. eCollection 2024.
3
Effectiveness of electroacupuncture for the treatment of refractory overactive bladder disease in women: study protocol for a randomised controlled clinical trial.
BMJ Open. 2025 Jul 18;15(7):e101864. doi: 10.1136/bmjopen-2025-101864.
4
Relevance of Leg Rehabilitation to Modulating Neurogenic Lower Urinary Tract Symptoms: A Systematic Review.
Bioengineering (Basel). 2025 Jan 29;12(2):127. doi: 10.3390/bioengineering12020127.
5
Efficacy and safety of sacral nerve root magnetic stimulation combined with solifenacin in female patients with overactive bladder.
Am J Transl Res. 2025 Jan 15;17(1):685-692. doi: 10.62347/EHTT9544. eCollection 2025.
6
Application of Augmented Reality for Accurate Punctures During Stage 1 Sacral Neuromodulation.
Int Neurourol J. 2024 Dec;28(4):302-311. doi: 10.5213/inj.2448330.165. Epub 2024 Dec 31.
7
Case report: Sacral neuromodulation for neurogenic lower urinary tract dysfunction in patient with neuronal intranuclear inclusion disease.
Heliyon. 2024 Jun 4;10(12):e32374. doi: 10.1016/j.heliyon.2024.e32374. eCollection 2024 Jun 30.
8
Awareness and barriers of sacral neuromodulation in women with overactive bladder.
Arch Gynecol Obstet. 2024 Oct;310(4):2273-2277. doi: 10.1007/s00404-024-07664-2. Epub 2024 Jul 31.
9
Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study.
Front Neurosci. 2024 Apr 10;18:1373375. doi: 10.3389/fnins.2024.1373375. eCollection 2024.
10
Sacral Neuromodulation: Device Improvement and Current Applications in Urology.
Medicina (Kaunas). 2024 Mar 20;60(3):509. doi: 10.3390/medicina60030509.
本文引用的文献
1
Twiddler's Syndrome: An Unusual Cause of Repeated Shocks by Implantable Cardioverter-Defibrillator in an Asymptomatic Patient.
Heart Views. 2019 Jul-Sep;20(3):118-121. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_45_19.
2
Electrical stimulation in the treatment of bladder dysfunction: technology update.
Med Devices (Auckl). 2019 Sep 11;12:337-345. doi: 10.2147/MDER.S179898. eCollection 2019.
3
Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.
J Urol. 2020 Jan;203(1):185-192. doi: 10.1097/JU.0000000000000458. Epub 2019 Jul 26.
4
Assessment of epidemiological obesity among adults in EU countries.
Ann Agric Environ Med. 2019 Jun 17;26(2):341-349. doi: 10.26444/aaem/97226. Epub 2018 Nov 26.
5
Success and Complication Rates After Sacral Neuromodulation for Fecal Incontinence and Constipation: A Single-center Follow-up Study.
J Neurogastroenterol Motil. 2019 Jan 31;25(1):159-170. doi: 10.5056/jnm17106.
6
A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
Neurourol Urodyn. 2019 Feb;38(2):689-695. doi: 10.1002/nau.23892. Epub 2018 Dec 28.
7
Long-Term Outcome Following Implanted Pulse Generator Change in Patients Treated With Sacral Nerve Modulation for Fecal Incontinence.
Neuromodulation. 2018 Oct;21(7):694-699. doi: 10.1111/ner.12806. Epub 2018 Aug 28.
8
Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: Which Do Patients Prefer?
Neuromodulation. 2019 Jun;22(4):489-492. doi: 10.1111/ner.12810. Epub 2018 Aug 22.
9
Can Lumbosacral Magnetic Resonance Imaging be Performed Safely in Patients with a Sacral Neuromodulation Device? An In Vivo Prospective Study.
J Urol. 2018 Nov;200(5):1088-1092. doi: 10.1016/j.juro.2018.05.095. Epub 2018 May 29.
10
International Continence Society best practice statement for use of sacral neuromodulation.
Neurourol Urodyn. 2018 Jun;37(5):1823-1848. doi: 10.1002/nau.23515. Epub 2018 Apr 11.
Zotero 插件